[go: up one dir, main page]

PE20070376A1 - METALLIC COMPLEXES WITH PERFLUOROALKYL CONTENT AND PROCEDURES FOR THEIR PREPARATION - Google Patents

METALLIC COMPLEXES WITH PERFLUOROALKYL CONTENT AND PROCEDURES FOR THEIR PREPARATION

Info

Publication number
PE20070376A1
PE20070376A1 PE2006000844A PE2006000844A PE20070376A1 PE 20070376 A1 PE20070376 A1 PE 20070376A1 PE 2006000844 A PE2006000844 A PE 2006000844A PE 2006000844 A PE2006000844 A PE 2006000844A PE 20070376 A1 PE20070376 A1 PE 20070376A1
Authority
PE
Peru
Prior art keywords
integer
sigma
radical
metallic
joint site
Prior art date
Application number
PE2006000844A
Other languages
Spanish (es)
Inventor
Heiko Schirmer
Ludwig Zorn
Jorg Meding
Thomas Brumby
Heribert Schmitt-Willich
Bernd Misselwitz
Hanns-Joachim Weinmann
Johannes Platzek
Original Assignee
Schering Ag
Epix Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag, Epix Pharm Inc filed Critical Schering Ag
Publication of PE20070376A1 publication Critical patent/PE20070376A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

REFERIDA A UN COMPLEJO CON CONTENIDO DE PERFLUOROALQUILO DE FORMULA (I), DONDE R ES UN RADICAL MONO- U OLIGOSACARIDO UNIDO A TRAVES DE UN OH; Q ES SIGMA-CO-(CH2)n''-E, SIGMA-NH-(CH2)n''-E, SIGMA-(CH2)m-E, DONDE n'' ES UN ENTERO DE 1 Y 5, m ES UN ENTERO DE 1 Y 6, DONDE SIGMA INDICA EL ITIO DE UNION CON EL LIGADOR Y E INDICA EL SITIO DE UNION CON EL RADICAL R; K ES UN COMPLEJO METALICO DE FORMULA II, III, IV, ENTRE OTROS, DONDE R1 ES H O UNEQUIVALENTE DE IONES METALICOS DE LOS NUMEROS ATOMICOS 21-29, 31-33, 37-39, 42-44, 49 O 57-83; R2 Y R3 SON H, ALQUILO C1-C7, BENCILO, ENTRE OTROS; U ES FENILENO, ALQUILENO C1-C12, ENTRE OTROS; R4 ES H O UN EQUIVALENTE METALICO TAL COMO EN R1; U1 ES -(CH2)p, ENTRE OTROS; p ES UN ENTERO ENTRE 1 Y 4; L ES UN GRUPO IXa) A IXb), DONDE n' Y m' SON UN ENTERO ENTRE 0 Y 4 Y m'+n' SON MAYOR O IGUAL A 1, R8 Y R8' SON H U OH; W ES O, FENILENO, ENLACE DIRECTO, ENTRE OTROS; q' ES UN ENTERO ENTRE 1 Y 4; ALFA ES EL SITIO DE UNION DE L CON EL COMPLEJO K, BETA ES EL SITIO DE UNION DE L CON EL RADICAL Q Y GAMMA ES EL SITIO DE UNION DE L CON EL RADICAL X; X ES UN GRUPO DE FORMULA VI, DONDE Y ES ENLACE DIRECTO, CO O NR6; R6 ES H O UNA CADENA DE CARBONOS C1-C15 LINEAL O RAMIFICADA, ENTRE OTROS; G ES O O SO2; s Y s' SON 1 O 2; t ES 0 O 1; p ES EL SITIO DE UNION DE X CON L Y E ES EL SITIO DE UNION DE X CON Rf. DICHO COMPLEJO METALICO ES UTIL EN EL DIAGNOSTICO POR RMN Y RAYOS X, EN EL RADIODIAGNOSTICO Y RADIOTERAPIAREFERRED TO A COMPLEX WITH PERFLUOROALKYL CONTENT OF FORMULA (I), WHERE R IS A RADICAL MONO- OR OLIGOSACARIDO JOINED THROUGH AN OH; Q IS SIGMA-CO- (CH2) n '' - E, SIGMA-NH- (CH2) n '' - E, SIGMA- (CH2) mE, WHERE n '' IS AN INTEGER OF 1 AND 5, m IS A INTEGRAL OF 1 AND 6, WHERE SIGMA INDICATES THE ITIO OF UNION WITH THE LIGATOR AND AND INDICATES THE SITE OF UNION WITH THE RADICAL R; K IS A METALLIC COMPLEX OF FORMULA II, III, IV, AMONG OTHERS, WHERE R1 IS H OR ANEQUIVALENT OF METALLIC IONS OF ATOMIC NUMBERS 21-29, 31-33, 37-39, 42-44, 49 OR 57-83; R2 AND R3 ARE H, C1-C7 ALKYL, BENZYL, AMONG OTHERS; U IS PHENYLENE, C1-C12 ALKYLENE, AMONG OTHERS; R4 IS H OR A METALLIC EQUIVALENT SUCH AS R1; U1 IS - (CH2) p, AMONG OTHERS; p IS AN INTEGER BETWEEN 1 AND 4; L IS A GROUP IXa) TO IXb), WHERE n 'AND m' ARE AN INTEGER BETWEEN 0 AND 4 AND m '+ n' ARE GREATER OR EQUAL TO 1, R8 AND R8 'ARE H U OH; W ES O, FENILENO, DIRECT LINK, AMONG OTHERS; q 'IS AN INTEGER BETWEEN 1 AND 4; ALPHA IS THE JOINT SITE OF L WITH THE K COMPLEX, BETA IS THE JOINT SITE OF L WITH THE RADICAL Q AND GAMMA IS THE JOINT SITE OF L WITH THE RADICAL X; X IS A GROUP OF FORMULA VI, WHERE Y IS A DIRECT LINK, CO OR NR6; R6 IS H OR A LINEAR OR BRANCHED C1-C15 CARBON CHAIN, AMONG OTHERS; G IS O O SO2; s AND s' ARE 1 O 2; t IS 0 O 1; p IS THE JOINT SITE OF X WITH L AND E IS THE JOINT SITE OF X WITH Rf. SAID METALLIC COMPLEX IS USEFUL IN DIAGNOSIS BY NMR AND X-RAYS, IN RADIODIAGNOSIS AND RADIOTHERAPY

PE2006000844A 2005-07-15 2006-07-14 METALLIC COMPLEXES WITH PERFLUOROALKYL CONTENT AND PROCEDURES FOR THEIR PREPARATION PE20070376A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005033902A DE102005033902B3 (en) 2005-07-15 2005-07-15 Perfluoroalkyl-containing complexes, processes for their preparation, and their use and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
PE20070376A1 true PE20070376A1 (en) 2007-04-20

Family

ID=37057146

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000844A PE20070376A1 (en) 2005-07-15 2006-07-14 METALLIC COMPLEXES WITH PERFLUOROALKYL CONTENT AND PROCEDURES FOR THEIR PREPARATION

Country Status (22)

Country Link
EP (1) EP1904463A2 (en)
JP (1) JP2009501174A (en)
KR (1) KR20080043762A (en)
CN (1) CN101223148A (en)
AR (1) AR054865A1 (en)
AU (1) AU2006272025A1 (en)
BR (1) BRPI0613407A2 (en)
CA (1) CA2615443A1 (en)
CR (1) CR9645A (en)
DE (1) DE102005033902B3 (en)
DO (1) DOP2006000167A (en)
EC (1) ECSP088100A (en)
GT (1) GT200600313A (en)
IL (1) IL187926A0 (en)
NO (1) NO20080813L (en)
PE (1) PE20070376A1 (en)
RU (1) RU2008105356A (en)
TN (1) TNSN08016A1 (en)
TW (1) TW200706538A (en)
UY (1) UY29664A1 (en)
WO (1) WO2007009638A2 (en)
ZA (1) ZA200801523B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007015598A1 (en) * 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Use of fluorochemical compounds for diagnostic purposes using imaging techniques
KR101595324B1 (en) 2008-01-08 2016-02-18 랜티우스 메디컬 이메징, 인크. N-alkoxyamide conjugates as imaging agents
CA3153519A1 (en) * 2019-10-04 2021-04-08 Bryan J. Traughber Development of imaging and therapeutic glucose analogues for sodium dependent glucose transporters
EP4059925A1 (en) 2021-03-15 2022-09-21 Bayer Aktiengesellschaft New contrast agent for use in magnetic resonance imaging
CN114181164A (en) * 2021-12-13 2022-03-15 武汉大学中南医院 Synthesis method and application of MRI contrast agent based on Fe (II) specificity
EP4335840A1 (en) 2022-09-09 2024-03-13 Bayer Aktiengesellschaft New contrast agents for use in diagnostic imaging
EP4335462A1 (en) 2022-09-09 2024-03-13 Bayer AG Contrast agents for use in diagnostic computed tomography imaging

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317588C2 (en) * 1993-05-24 1998-04-16 Schering Ag Macrocyclic metal complexes containing fluorine, process for their preparation and their use
DE19603033A1 (en) * 1996-01-19 1997-07-24 Schering Ag Perfluoroalkyl-containing metal complexes, processes for their preparation and their use in NMR diagnostics
DE19744003B4 (en) * 1997-09-26 2004-07-08 Schering Ag Contrast agent for infarct and necrosis imaging
DE19744004C1 (en) * 1997-09-26 1999-07-22 Schering Ag Lipophilic metal complexes for necrosis and infarct imaging
DE19914101C1 (en) * 1999-03-22 2000-10-12 Schering Ag Perfluoroalkylamides, their preparation and their use in diagnostics
DE10040858C2 (en) * 2000-08-11 2003-12-18 Schering Ag Perfluoroalkyl-containing complexes with polar residues, process for their preparation and their use

Also Published As

Publication number Publication date
IL187926A0 (en) 2008-03-20
CN101223148A (en) 2008-07-16
WO2007009638A2 (en) 2007-01-25
BRPI0613407A2 (en) 2011-01-11
DOP2006000167A (en) 2007-02-28
KR20080043762A (en) 2008-05-19
ZA200801523B (en) 2008-11-26
ECSP088100A (en) 2008-05-30
UY29664A1 (en) 2007-02-28
TW200706538A (en) 2007-02-16
CR9645A (en) 2008-05-21
NO20080813L (en) 2008-04-09
RU2008105356A (en) 2009-08-20
AU2006272025A1 (en) 2007-01-25
CA2615443A1 (en) 2007-01-25
TNSN08016A1 (en) 2009-07-14
AR054865A1 (en) 2007-07-25
JP2009501174A (en) 2009-01-15
GT200600313A (en) 2007-04-23
WO2007009638A3 (en) 2007-04-26
EP1904463A2 (en) 2008-04-02
DE102005033902B3 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
PE20070376A1 (en) METALLIC COMPLEXES WITH PERFLUOROALKYL CONTENT AND PROCEDURES FOR THEIR PREPARATION
CL2012000284A1 (en) Pyrimidinium derived compounds; and composition comprising said compound and at least one biologically active agent.
AR073922A1 (en) 2- OXOQUINOXALINAS AS BLOCKERS OF THE LATER SODIUM CHANNELS
UY32805A (en) FUSIONED HETEROCYCLIC COMPOUNDS AS IONIC CHANNEL MODULATORS, TREATMENT METHOD AND COMPOSITIONS CONTAINING THEM
CO6351754A2 (en) CONTRAST AGENTS THAT INCLUDE FENILO YODADOS COMPOUNDS
PE20030727A1 (en) 17OALKYL-17ß-OXI-STRATRENES, INTERMEDIARY PRODUCTS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE355039T1 (en) FLAT IMPLANT WITH X-RAY VISIBLE ELEMENTS
TW200609328A (en) Light-emitting element material and light-emitting material
Santos Recent developments on 3-hydroxy-4-pyridinones with respect to their clinical applications: mono and combined ligand approaches
ES2169597T3 (en) NICKEL-IRON MAGNETIC ALLOY OF LOW ENERGY WITH LOW INTENSITY OF THE COERCIVO FIELD, HIGH PERMEABILITY AND IMPROVED CORROSION RESISTANCE.
NO20040179L (en) Multivariate aza ligands capable of complexing metal ions and their use in diagnosis and therapy
BRPI0409230A (en) dosage forms comprising ag013736
CO6230990A2 (en) NEW TRICYCLE DERIVATIVES ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PE20110001A1 (en) DERIVATIVES OF TAXANS AS CYTOTOXIC AGENTS
Duan et al. A membrane permeable fluorescent Ca 2+ probe based on bis-BODIPY with branched PEG
Sabbatini et al. Lanthanide luminescence in supramolecular species
RU2013118021A (en) METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES MELLITUS AND DYSLIPIDEMIA
RU2015122032A (en) OXAZOLIDIN CONTAINING COMPOUNDS, COMPOSITIONS AND METHODS FOR USING THEM
AR059113A1 (en) COMPOSITION FOR TOPICAL ADMINISTRATION
AR056606A1 (en) SOLID PHYTOSANITARY AGENTS WITH POLYCOXYXYLATE CONTENT PROCEDURE FOR PREPARATION AND USE
AR035342A1 (en) COMPLEXES CONTAINING PERFLUORALQUILO WITH POLAR RADICALS, METHOD FOR OBTAINING AND USING THE SAME
AR055200A1 (en) METALLIC COMPLEXES WITH CONTENT OF PERFLUOR OR RENT PROCEDURES FOR THEIR PREPARATION, AS WELL AS THEIR USE
AR083846A1 (en) DERIVATIVES OF OXIMA AS MICROBICIDES
CO5200761A1 (en) NEW DERIVATIVES OF EQUINOCANDINA, ITS PREPARATION PROCEDURE AND ITS APPLICATION AS ANTIFUNGICOS
AR064232A1 (en) USE OF METALLIC COMPLEXES CONTAINING PERFLUOROALQUILO AS A CONTRAST MEASURE FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE

Legal Events

Date Code Title Description
FC Refusal